Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.
Identifieur interne : 000618 ( PubMed/Checkpoint ); précédent : 000617; suivant : 000619Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.
Auteurs : Barbara Connolly [Canada] ; Susan H. FoxSource :
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [ 1878-7479 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease.
- etiology : Cognition Disorders, Mental Disorders, Mood Disorders.
- therapy : Cognition Disorders, Mental Disorders, Mood Disorders.
- Animals, Humans.
Abstract
Neuropsychiatric symptoms are common in Parkinson's disease (PD) and add significantly to the burden of disease. These symptoms are most commonly part of the disease spectrum owing to pathological changes within relevant brain regions. Neuropsychiatric problems include disorders of cognition, ranging from mild cognitive impairment to dementia, psychotic symptoms, including, most commonly, well-formed visual hallucinations and paranoid delusions, and mood disorders, such as depression and anxiety. The other common cause of neuropsychiatric problem is secondary to use of dopaminergic drugs. Some PD patients may develop behavioral disorders, including impulse control disorders (ICDs) and addictive symptoms. Psychosis can be due to a mixture of underlying pathology, with triggering or worsening of symptoms with changes to PD medications. Currently, management of these disorders primarily uses therapies developed for general psychiatry and cognitive neurology, rather than specifically for PD. However, significant adverse effects, such as worsening of the motor symptoms of PD, can limit use of some drug therapies. Identification of drug-induced symptoms, such as ICDs, enables withdrawal of the offending drug as the principal management strategy. Research is ongoing in an effort to develop more specific therapies for PD-related neuropsychiatric symptoms.
DOI: 10.1007/s13311-013-0238-x
PubMed: 24288035
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24288035Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.</title><author><name sortKey="Connolly, Barbara" sort="Connolly, Barbara" uniqKey="Connolly B" first="Barbara" last="Connolly">Barbara Connolly</name><affiliation wicri:level="4"><nlm:affiliation>Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hamilton Health Sciences, McMaster University, Hamilton, Ontario</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24288035</idno><idno type="pmid">24288035</idno><idno type="doi">10.1007/s13311-013-0238-x</idno><idno type="wicri:Area/PubMed/Corpus">000819</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000819</idno><idno type="wicri:Area/PubMed/Curation">000819</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000819</idno><idno type="wicri:Area/PubMed/Checkpoint">000819</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000819</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.</title><author><name sortKey="Connolly, Barbara" sort="Connolly, Barbara" uniqKey="Connolly B" first="Barbara" last="Connolly">Barbara Connolly</name><affiliation wicri:level="4"><nlm:affiliation>Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Hamilton Health Sciences, McMaster University, Hamilton, Ontario</wicri:regionArea><orgName type="university">Université McMaster</orgName><placeName><settlement type="city">Hamilton (Ontario)</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name></author></analytic><series><title level="j">Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</title><idno type="eISSN">1878-7479</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Cognition Disorders (etiology)</term><term>Cognition Disorders (therapy)</term><term>Humans</term><term>Mental Disorders (etiology)</term><term>Mental Disorders (therapy)</term><term>Mood Disorders (etiology)</term><term>Mood Disorders (therapy)</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term><term>Mental Disorders</term><term>Mood Disorders</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Cognition Disorders</term><term>Mental Disorders</term><term>Mood Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Neuropsychiatric symptoms are common in Parkinson's disease (PD) and add significantly to the burden of disease. These symptoms are most commonly part of the disease spectrum owing to pathological changes within relevant brain regions. Neuropsychiatric problems include disorders of cognition, ranging from mild cognitive impairment to dementia, psychotic symptoms, including, most commonly, well-formed visual hallucinations and paranoid delusions, and mood disorders, such as depression and anxiety. The other common cause of neuropsychiatric problem is secondary to use of dopaminergic drugs. Some PD patients may develop behavioral disorders, including impulse control disorders (ICDs) and addictive symptoms. Psychosis can be due to a mixture of underlying pathology, with triggering or worsening of symptoms with changes to PD medications. Currently, management of these disorders primarily uses therapies developed for general psychiatry and cognitive neurology, rather than specifically for PD. However, significant adverse effects, such as worsening of the motor symptoms of PD, can limit use of some drug therapies. Identification of drug-induced symptoms, such as ICDs, enables withdrawal of the offending drug as the principal management strategy. Research is ongoing in an effort to develop more specific therapies for PD-related neuropsychiatric symptoms.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24288035</PMID><DateCreated><Year>2014</Year><Month>01</Month><Day>23</Day></DateCreated><DateCompleted><Year>2014</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1878-7479</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics</Title><ISOAbbreviation>Neurotherapeutics</ISOAbbreviation></Journal><ArticleTitle>Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>78-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13311-013-0238-x</ELocationID><Abstract><AbstractText>Neuropsychiatric symptoms are common in Parkinson's disease (PD) and add significantly to the burden of disease. These symptoms are most commonly part of the disease spectrum owing to pathological changes within relevant brain regions. Neuropsychiatric problems include disorders of cognition, ranging from mild cognitive impairment to dementia, psychotic symptoms, including, most commonly, well-formed visual hallucinations and paranoid delusions, and mood disorders, such as depression and anxiety. The other common cause of neuropsychiatric problem is secondary to use of dopaminergic drugs. Some PD patients may develop behavioral disorders, including impulse control disorders (ICDs) and addictive symptoms. Psychosis can be due to a mixture of underlying pathology, with triggering or worsening of symptoms with changes to PD medications. Currently, management of these disorders primarily uses therapies developed for general psychiatry and cognitive neurology, rather than specifically for PD. However, significant adverse effects, such as worsening of the motor symptoms of PD, can limit use of some drug therapies. Identification of drug-induced symptoms, such as ICDs, enables withdrawal of the offending drug as the principal management strategy. Research is ongoing in an effort to develop more specific therapies for PD-related neuropsychiatric symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Connolly</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Susan H</ForeName><Initials>SH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotherapeutics</MedlineTA><NlmUniqueID>101290381</NlmUniqueID><ISSNLinking>1878-7479</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Neurother. 2012 Dec;12(12):1451-66</RefSource><PMID Version="1">23237352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Geriatr Psychiatry Neurol. 2013 Jun;26(2):95-104</RefSource><PMID Version="1">23584852</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 May 15;23(7):964-9</RefSource><PMID Version="1">18398913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Neurol. 2013 Jan 1;27(4):501-13</RefSource><PMID Version="1">23242365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurocase. 2012;18(2):152-9</RefSource><PMID Version="1">21919560</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2013 Feb 26;80(9):792-9</RefSource><PMID Version="1">23325911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2002 Sep 1;52(5):438-45</RefSource><PMID Version="1">12242060</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2010 Aug;67(8):996-1001</RefSource><PMID Version="1">20697051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2005 Aug;20(8):958-63</RefSource><PMID Version="1">15800937</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2011 Mar;258(3):494-9</RefSource><PMID Version="1">20957384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychopharmacol. 2013 Oct;33(5):691-4</RefSource><PMID Version="1">23857310</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):868-74</RefSource><PMID Version="1">23447648</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2012 Apr 15;27(5):617-26</RefSource><PMID Version="1">22508280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Aug 15;24(11):1561-70</RefSource><PMID Version="1">19526584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Psychogeriatr. 2003 Jun;15(2):181-6</RefSource><PMID Version="1">14620076</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2009 Mar;15(3):196-204</RefSource><PMID Version="1">18602855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S74-6</RefSource><PMID Version="1">22166461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Emerg Med. 2000 Mar;18(2):209-15</RefSource><PMID Version="1">10750935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2010 May;67(5):589-95</RefSource><PMID Version="1">20457959</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Psychogeriatr. 2011 Mar;23(2):325-7</RefSource><PMID Version="1">20809995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2013 Jan 8;80(2):176-80</RefSource><PMID Version="1">23296128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2002 Sep;17(5):1031-5</RefSource><PMID Version="1">12360554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):708-12</RefSource><PMID Version="1">12023410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Neurosci. 2009;119(12):2196-205</RefSource><PMID Version="1">19916848</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):308-12</RefSource><PMID Version="1">10945804</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 May;26(6):1022-31</RefSource><PMID Version="1">21626547</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2011 Mar;17(3):156-9</RefSource><PMID Version="1">21193343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 Sep 15;25(12):1994-5</RefSource><PMID Version="1">20669252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Oct 25;65(8):1239-45</RefSource><PMID Version="1">16247051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Pract. 2010 Jan;64(2):188-93</RefSource><PMID Version="1">20089009</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Geriatr Psychiatry. 2004 Jan;19(1):1-8</RefSource><PMID Version="1">14716693</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Aug;21(8):1119-22</RefSource><PMID Version="1">16637039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurosci Biobehav Rev. 2008;32(1):175-91</RefSource><PMID Version="1">17884165</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2005 Jul-Aug;28(4):176-8</RefSource><PMID Version="1">16062096</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2010 Apr;67(4):416-21</RefSource><PMID Version="1">20385906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2012 Nov-Dec;35(6):261-5</RefSource><PMID Version="1">23123689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2009 Nov;132(Pt 11):2980-93</RefSource><PMID Version="1">19755518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2005 Sep;11(6):381-6</RefSource><PMID Version="1">16109498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Neurosci. 2009 Sep;16(9):1148-52</RefSource><PMID Version="1">19553125</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Jan 30;23(2):183-9; quiz 313</RefSource><PMID Version="1">17987654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Depress Anxiety. 2000;11(4):185-6</RefSource><PMID Version="1">10945141</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2012 May-Jun;35(3):118-20</RefSource><PMID Version="1">22426027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2010 Jun;9(6):573-80</RefSource><PMID Version="1">20452823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2011 Nov 15;310(1-2):220-4</RefSource><PMID Version="1">21802694</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychopharmacol. 2003 Oct;23(5):509-13</RefSource><PMID Version="1">14520130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychopharmacol. 2007 Feb;27(1):107-8</RefSource><PMID Version="1">17224732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2013 Jul;28(8):1097-103</RefSource><PMID Version="1">23630134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 1998 May;13(3):377-82</RefSource><PMID Version="1">9613725</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2006 Nov-Dec;29(6):331-7</RefSource><PMID Version="1">17095896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2009 Feb;66(2):167-72</RefSource><PMID Version="1">19204152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2004 Aug;110(2):118-23</RefSource><PMID Version="1">15242420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2002 Jan;17(1):221-2</RefSource><PMID Version="1">11835472</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837</RefSource><PMID Version="1">17542011</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2006 May;253(5):601-7</RefSource><PMID Version="1">16607468</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2010 Mar;35(4):881-92</RefSource><PMID Version="1">19907417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Neurol Scand. 2010 Dec;122(6):418-24</RefSource><PMID Version="1">20175757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Convuls Ther. 1992;8(3):204-210</RefSource><PMID Version="1">11941171</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Geriatr Psychiatry. 2006 Mar;21(3):252-8</RefSource><PMID Version="1">16477585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychiatry. 2002 Apr;63(4):300-4</RefSource><PMID Version="1">12000202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Jan;23(1):75-80</RefSource><PMID Version="1">17960796</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Nov;21(11):1941-6</RefSource><PMID Version="1">16972268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2004 May;75(5):689-95</RefSource><PMID Version="1">15090561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2005 Feb;20(2):190-9</RefSource><PMID Version="1">15551331</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2001 May 8;56(9):1154-66</RefSource><PMID Version="1">11342679</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 Oct;26 Suppl 3:S42-80</RefSource><PMID Version="1">22021174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):491-7</RefSource><PMID Version="1">15774433</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Geriatr Psychiatry. 2003 Jun;18(6):552-4</RefSource><PMID Version="1">12789682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2004 Jan;3(1):19-28</RefSource><PMID Version="1">14693108</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2000 Dec 16;356(9247):2031-6</RefSource><PMID Version="1">11145488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1999 Mar 11;340(10):757-63</RefSource><PMID Version="1">10072410</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Dec;21(12):2078-81</RefSource><PMID Version="1">17013906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J ECT. 2008 Jun;24(2):171-2</RefSource><PMID Version="1">18580566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2010 Sep;68(3):400-4</RefSource><PMID Version="1">20687121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S111-5</RefSource><PMID Version="1">20123548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2009 Apr;256(4):632-8</RefSource><PMID Version="1">19370301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Nov 22;65(10):1570-4</RefSource><PMID Version="1">16301483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neural Transm Suppl. 2006;(71):27-30</RefSource><PMID Version="1">17447412</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychology. 2010 Nov;24(6):721-30</RefSource><PMID Version="1">20853956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Ther. 2005 Sep-Oct;12(5):467-8</RefSource><PMID Version="1">16148432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dement Geriatr Cogn Disord. 2007;23(3):161-7</RefSource><PMID Version="1">17192712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2011 Apr 5;76(14):1256-62</RefSource><PMID Version="1">21464430</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8</RefSource><PMID Version="1">10727476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2004 Apr;19(4):397-405</RefSource><PMID Version="1">15077237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Jun 15;24(8):1217-21</RefSource><PMID Version="1">19370737</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2011 Mar;17(3):182-8</RefSource><PMID Version="1">21256069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2012 Jul;72(1):41-52</RefSource><PMID Version="1">22829268</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2010 Oct;9(10):969-77</RefSource><PMID Version="1">20729148</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Feb 15;22(3):313-8</RefSource><PMID Version="1">17034006</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurocase. 2013;19(6):587-91</RefSource><PMID Version="1">22934916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drugs. 2011 Feb 12;71(3):273-86</RefSource><PMID Version="1">21319866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Aug 15;24(11):1641-9</RefSource><PMID Version="1">19514014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2001 May-Jun;24(3):170-2</RefSource><PMID Version="1">11391129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2009 Nov;132(Pt 11):2958-69</RefSource><PMID Version="1">19812213</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Neurol. 2003 Jul;10(4):399-406</RefSource><PMID Version="1">12823492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Jan 30;24(2):277-82</RefSource><PMID Version="1">19025777</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Sep;21(9):1343-9</RefSource><PMID Version="1">16721732</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Nov;21(11):1899-907</RefSource><PMID Version="1">16960863</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Dement Geriatr Cogn Disord. 2010;29(6):510-5</RefSource><PMID Version="1">20523050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2004 Dec 9;351(24):2509-18</RefSource><PMID Version="1">15590953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychopharmacol. 2012 Jun;32(3):424-5</RefSource><PMID Version="1">22534502</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2010 Jan;67(1):58-63</RefSource><PMID Version="1">20065130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2008;14(5):448-9</RefSource><PMID Version="1">18339573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2004 Apr;19(4):433-7</RefSource><PMID Version="1">15077241</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Apr 30;23(6):850-7</RefSource><PMID Version="1">18311826</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Brain. 2002 Feb;125(Pt 2):391-403</RefSource><PMID Version="1">11844739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 Aug 15;26(10):1851-8</RefSource><PMID Version="1">21500280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2010 Aug 3;75(5):448-55</RefSource><PMID Version="1">20679638</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2009 Nov 3;73(18):1469-77</RefSource><PMID Version="1">19884574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):102-10</RefSource><PMID Version="1">22450620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2011 Aug 15;26(10):1814-24</RefSource><PMID Version="1">21661055</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CNS Drugs. 2009;23(2):157-70</RefSource><PMID Version="1">19173374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Opin Pharmacother. 2011 Sep;12(13):2009-24</RefSource><PMID Version="1">21635198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2009 Mar 10;72(10):886-92</RefSource><PMID Version="1">19092112</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011;342:d1199</RefSource><PMID Version="1">21398351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2012 Jul;11(7):589-96</RefSource><PMID Version="1">22658702</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2012 Mar;27(3):349-56</RefSource><PMID Version="1">22275317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):443-9</RefSource><PMID Version="1">22009228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Neurol. 2010;10:49</RefSource><PMID Version="1">20565960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(12):25-33</RefSource><PMID Version="1">18427456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CNS Neurosci Ther. 2010 Dec;16(6):330-6</RefSource><PMID Version="1">20950329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2004 Mar 23;62(6 Suppl 4):S12-7</RefSource><PMID Version="1">15037666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2004 Jul-Aug;27(4):153-6</RefSource><PMID Version="1">15319699</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2013 Jul 23;81(4):346-52</RefSource><PMID Version="1">23794682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2012;3:CD006504</RefSource><PMID Version="1">22419314</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Psychopharmacol. 2013 May;27(5):417-23</RefSource><PMID Version="1">23427193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2001 Jan;16(1):135-9</RefSource><PMID Version="1">11215574</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2013 Jul;19(7):660-5</RefSource><PMID Version="1">23557594</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2007 Jul 24;69(4):342-7</RefSource><PMID Version="1">17581943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ther Adv Neurol Disord. 2013 May;6(3):175-88</RefSource><PMID Version="1">23634190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1999 Jun 12;353(9169):2041-2</RefSource><PMID Version="1">10376627</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Neurol. 2013 Jan 1;27(4):469-77</RefSource><PMID Version="1">23242358</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 May 15;25(7):838-45</RefSource><PMID Version="1">20461800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2013 Jul;28(8):1034-49</RefSource><PMID Version="1">23426759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Geriatr Psychiatry. 2003 Oct;18(10):937-41</RefSource><PMID Version="1">14533126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2012 Sep 1;27(10):1230-8</RefSource><PMID Version="1">22915447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1994 Sep 3;344(8923):681</RefSource><PMID Version="1">7520964</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2009 Dec 15;24(16):2391-7</RefSource><PMID Version="1">19908317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharm Pract. 2011 Dec;24(6):534-40</RefSource><PMID Version="1">22095576</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1997 Apr;48(4):1070-7</RefSource><PMID Version="1">9109902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Nov 22;65(10):1654-6</RefSource><PMID Version="1">16301500</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2011 Oct;168(10):1066-74</RefSource><PMID Version="1">21676990</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 Apr 30;25(6):763-6</RefSource><PMID Version="1">20437542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Jan;23(1):129-30</RefSource><PMID Version="1">17960816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2012 Mar-Apr;35(2):61-6</RefSource><PMID Version="1">22388466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Geriatr Psychiatry Neurol. 2012 Dec;25(4):208-14</RefSource><PMID Version="1">23172765</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Saf. 2008;31(1):79-94</RefSource><PMID Version="1">18095748</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Geriatr Soc. 2000 Aug;48(8):938-42</RefSource><PMID Version="1">10968298</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2002;40(13):2257-67</RefSource><PMID Version="1">12417456</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9</RefSource><PMID Version="1">15965198</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Rev Neurol. 2012 Jan;8(1):35-47</RefSource><PMID Version="1">22198405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2010 Oct;257(10):1682-5</RefSource><PMID Version="1">20509031</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Convuls Ther. 1992;8(3):201-203</RefSource><PMID Version="1">11941170</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Hypotheses. 2010 Dec;75(6):544-6</RefSource><PMID Version="1">20708340</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2009 Jul;8(7):613-8</RefSource><PMID Version="1">19520613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2007 Jul;64(7):984-8</RefSource><PMID Version="1">17620488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):130-5</RefSource><PMID Version="1">22933817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2011 Apr;258(4):656-60</RefSource><PMID Version="1">21072531</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2013 May;28(5):626-33</RefSource><PMID Version="1">23520128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Health Psychol. 2012 Oct;17(7):1076-88</RefSource><PMID Version="1">22214559</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Sci. 2010 Feb 15;289(1-2):18-22</RefSource><PMID Version="1">19733364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2013 Feb 26;80(9):800-9</RefSource><PMID Version="1">23365054</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2012 Apr 17;78(16):1229-36</RefSource><PMID Version="1">22496199</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2006 Jan-Feb;29(1):15-7</RefSource><PMID Version="1">16518128</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neurol Neurosurg. 2007 Feb;109(2):188-91</RefSource><PMID Version="1">16949733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2010 Dec;68(6):963-8</RefSource><PMID Version="1">21154480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2007 May;78(5):517-9</RefSource><PMID Version="1">17210626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2005 Dec 27;65(12):1863-72</RefSource><PMID Version="1">16237129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2008 Oct;1142:85-107</RefSource><PMID Version="1">18990123</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Neurol. 2013 Feb;260(2):521-7</RefSource><PMID Version="1">23007193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Geriatr Psychiatry Neurol. 2011 Dec;24(4):206-14</RefSource><PMID Version="1">22228827</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019964" MajorTopicYN="N">Mood Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3899484</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24288035</ArticleId><ArticleId IdType="doi">10.1007/s13311-013-0238-x</ArticleId><ArticleId IdType="pmc">PMC3899484</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Hamilton (Ontario)</li></settlement><orgName><li>Université McMaster</li></orgName></list><tree><noCountry><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name></noCountry><country name="Canada"><region name="Ontario"><name sortKey="Connolly, Barbara" sort="Connolly, Barbara" uniqKey="Connolly B" first="Barbara" last="Connolly">Barbara Connolly</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000618 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000618 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24288035
|texte= Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24288035" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |